Showing results (391-400 of 401) with videos related to
Sort By:
Pageof 41
Hormones (Athens, Greece)|December 16, 2025
Pineal gland senescence: an emerging ageing-related pathology?Emma Short, Ramzi Ajjan, Thomas M Barber, et al.Neuron|June 24, 2020
Soma-Targeted Imaging of Neural Circuits by Ribosome TetheringYiming Chen, Heeun Jang, Perry W E Spratt, et al.Journal of Hepatology|March 4, 2015
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infectionEdward J Gane, Young-Suk Lim, Stuart C Gordon, et al.Nature Aging|June 17, 2026
Aging disrupts spatiotemporal coordination in the cycling murine ovaryTammy C T Lan, Alison Kochersberger, Ruth Raichur, et al.Hepatology (Baltimore, Md.)|August 3, 2018
Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11Karen F Murray, William F Balistreri, Sanjay Bansal, et al.Journal of Gastroenterology and Hepatology|February 5, 2016
Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virusWan-Long Chuang, Rong-Nan Chien, Cheng-Yuan Peng, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trialJ M Vose, A N Pandite, R A Beveridge, et al.Annals of Internal Medicine|March 13, 1999
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trialL W Moreland, M H Schiff, S W Baumgartner, et al.Hepatology International|May 21, 2016
A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virusYoung-Suk Lim, Sang Hoon Ahn, Kwan Sik Lee, et al.Journal of Viral Hepatitis|September 9, 2014
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trialMasao Omata, Shuhei Nishiguchi, Yoshiyuki Ueno, et al.Pageof 41